84 related articles for article (PubMed ID: 122631)
1. The potential uses of the medication monitor in the treatment of leprosy.
Moulding TS
Int J Lepr Other Mycobact Dis; 1979 Dec; 47(4):601-6. PubMed ID: 122631
[TBL] [Abstract][Full Text] [Related]
2. The medication monitor for treating tuberculosis in the developing countries.
Moulding T
Trop Doct; 1979 Jul; 9(3):106-9. PubMed ID: 494382
[TBL] [Abstract][Full Text] [Related]
3. Managing medication compliance of tuberculosis patients in Haiti with medication monitors.
Moulding TS; Caymittes M
Int J Tuberc Lung Dis; 2002 Apr; 6(4):313-9. PubMed ID: 11936740
[TBL] [Abstract][Full Text] [Related]
4. Viewpoint: adapting to new international tuberculosis treatment standards with medication monitors and DOT given selectively.
Moulding TS
Trop Med Int Health; 2007 Nov; 12(11):1302-8. PubMed ID: 17949402
[TBL] [Abstract][Full Text] [Related]
5. Irregularity of Dapsone intake in infectious leprosy patients attending an urban treatment centre--its magnitude and causes.
Naik SS
Lepr India; 1978 Jan; 50(1):45-53. PubMed ID: 651317
[TBL] [Abstract][Full Text] [Related]
6. Operational study to monitor the regularity of dapsone intake by leprosy out-patients.
Kumar A; Balakrishnan S
Lepr India; 1983 Jul; 55(3):521-7. PubMed ID: 6656209
[TBL] [Abstract][Full Text] [Related]
7. Patient compliance in rheumatoid arthritis, polymyalgia rheumatica, and gout.
de Klerk E; van der Heijde D; Landewé R; van der Tempel H; Urquhart J; van der Linden S
J Rheumatol; 2003 Jan; 30(1):44-54. PubMed ID: 12508389
[TBL] [Abstract][Full Text] [Related]
8. Comparison of a urine spot test and blood tests as indicators of patient compliance.
Yoder LJ; Guitrau M; Jacobson R
Indian J Lepr; 1991; 63(2):195-202. PubMed ID: 1783788
[TBL] [Abstract][Full Text] [Related]
9. Monitoring medication compliance: description of a new device.
Eisen SA; Hanpeter JA; Kreuger LW; Gard M
J Compliance Health Care; 1987; 2(2):131-42. PubMed ID: 10284597
[TBL] [Abstract][Full Text] [Related]
10. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
11. New lesions after MDT in PB and MB leprosy: a report of 28 cases.
Kar HK; Sharma P
Indian J Lepr; 2008; 80(3):247-55. PubMed ID: 19432355
[TBL] [Abstract][Full Text] [Related]
12. Field trial on efficacy of supervised monthly dose of 600 mg rifampin, 400 mg ofloxacin and 100 mg minocycline for the treatment of leprosy; first results.
Mane I; Cartel JL; Grosset JH
Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):224-9. PubMed ID: 9251595
[TBL] [Abstract][Full Text] [Related]
13. ELISA inhibition technique for the demonstration of sulphones in body fluids. II. A new method to monitor leprosy patient compliance under field conditions.
Huikeshoven H; de Wit M; Soeters A; Landheer J; Leiker DL
Lepr Rev; 1981 Mar; 52(1):11-8. PubMed ID: 7017317
[No Abstract] [Full Text] [Related]
14. Medication noncompliance: an issue to consider in the drug selection process.
Feldman JA; DeTullio PL
Hosp Formul; 1994 Mar; 29(3):204-11. PubMed ID: 10132693
[TBL] [Abstract][Full Text] [Related]
15. Field application of combined therapy for infectious leprosy cases. A feasibility study in Bombay.
Ganapati R; Revankar CR; Naik SS
Lepr India; 1983 Jul; 55(3):485-9. PubMed ID: 6656206
[TBL] [Abstract][Full Text] [Related]
16. [Autonomy attitudes in the treatment compliance of a cohort of subjects with continuous psychotropic drug administration].
Baumann M; Trincard M
Encephale; 2002; 28(5 Pt 1):389-96. PubMed ID: 12386539
[TBL] [Abstract][Full Text] [Related]
17. [Multi-drug therapy trials for leprosy in Senegal: first observations relative to liver tolerance of multibacillary patients. Therapeutic consequences].
Millan J; Roux G; Loko S; Naudin JC; Boucher P; Bodian M; Camara M; Moreira-Diop T; Grosset J
Acta Leprol; 1986; 4(4):427-44. PubMed ID: 3296613
[TBL] [Abstract][Full Text] [Related]
18. Comparison of three regimens containing rifampin for treatment of paucibacillary leprosy patients.
Katoch K; Ramu G; Ramanathan U; Desikan KV
Int J Lepr Other Mycobact Dis; 1987 Mar; 55(1):1-8. PubMed ID: 3559333
[TBL] [Abstract][Full Text] [Related]
19. Tile test to monitor the self administration of dapsone by leprosy patients.
Naik SS
Lepr India; 1983 Oct; 55(4):665-9. PubMed ID: 6668922
[TBL] [Abstract][Full Text] [Related]
20. Noncompliance with the world health organization-multidrug therapy among leprosy patients in Cebu, Philippines: its causes and implications on the leprosy control program.
Honrado ER; Tallo V; Balis AC; Chan GP; Cho SN
Dermatol Clin; 2008 Apr; 26(2):221-9, vi. PubMed ID: 18346553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
